ArticleFrontiers in pharmacology2025

Efficacy and safety of different proprotein convertase subtilisin/kexin type 9 inhibitors in the general population and solid organ transplant recipients: a network meta-analysis.

Bohan Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.